PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,039 | -19.8% | 13,107 | 0.0% | 0.00% | -50.0% |
Q2 2023 | $21,233 | -23.9% | 13,107 | 0.0% | 0.01% | -46.7% |
Q1 2023 | $27,918 | -59.3% | 13,107 | -29.2% | 0.02% | -55.9% |
Q4 2022 | $68,531 | +226.3% | 18,522 | -35.7% | 0.03% | +385.7% |
Q3 2022 | $21,000 | -12.5% | 28,821 | -5.3% | 0.01% | -30.0% |
Q2 2022 | $24,000 | -14.3% | 30,422 | 0.0% | 0.01% | -23.1% |
Q1 2022 | $28,000 | – | 30,422 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |